Asia Pacific Preterm Labor Treatment Market Size, Share, Growth, Trends and Industry Analysis: By Drugs, By Dosage Form, By End user and Country Forecast 2020-2031

Asia Pacific Preterm Labor Treatment Market Size, Share, Growth, Trends and Industry Analysis: By Drugs (Tocolytic Drugs, Beta Mimetic, Calcium Channel Blockers, NSAIDS, Corticosteroids, Magnesium Sulphate, Antibiotics, Others), By Dosage Form (Tablets, Capsules, Injections), By End user (Hospitals, Pediatric and Neonatal Clinics, Nursing Homes, Pharmacy) and Country Forecast 2020-2031

Asia Pacific Preterm Labor Treatment Market size was valued at US$ 579.25 million in 2024 and is expected to reach US$ 1,045.37 million by 2031, growing at a significant CAGR of 8.8% from 2025-2031. Increase in technological advancements, increasing demand for preterm therapeutics and diagnostics, increase in support of government, increase in R&D investments by market players are expected to propel the growth of preterm labor treatment market. However, lack of awareness, stringent regulatory framework, high costs associated with the treatment will hamper the growth of preterm labor treatment market.

Asia Pacific Preterm Labor Treatment Market Dynamics

Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market. As per WHO statistics, every year 15Mn babies are born.

Asia Pacific Preterm Labor Treatment Market Segmentation Analysis

Report Benchmarks

Details

Market Size in 2024

US$ 579.25 million

Market Size in 2031

US$ 1,045.37 million

By Drugs Type

  • Tocolytic Drugs
  • Beta Mimetic
  • Calcium Channel Blockers
  • NSAIDS
  • Corticosteroids
  • Magnesium Sulphate
  • Antibiotics
  • Others

By Dosage form

  • Tablets
  • Capsules
  • Injection

By End User

  • Hospitals
  • Pediatric and Neonatal Clinics
  • Nursing Homes
  • Pharmacy

Key Features of the Report

  • The asia pacific preterm labor treatment market report provides granular level information about the market size, regional market share, historic market (2020 to 2024) and forecast (2025 to 2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

Asia Pacific preterm labor treatment market size was valued at US$ 579.25 million in 2024 and is expected to reach US$ 1,045.37 million by 2031, growing at a significant CAGR of 8.8% from 2025-2031.

The report covers the market data: China, India, Japan, Australia & New Zealand

The market key players are Pfizer, Novartis, Merck & Co, Sanofi, Johnson and Johnson, GlaxoSmithKline, AstraZeneca, Cipla

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2. Asia Pacific Preterm Labor Treatment Market Introduction 
2.1. Asia Pacific Preterm Labor Treatment Market  - Taxonomy
2.2. Asia Pacific Preterm Labor Treatment Market  - Definitions
2.2.1.Drugs Type
2.2.2.Dosage form
2.2.3.End User
2.2.4.Country
3. Asia Pacific Preterm Labor Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Asia Pacific Preterm Labor Treatment Market Analysis, 2020-2024 and Forecast 2024-2031
4.1.  Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Asia Pacific Preterm Labor Treatment Market By Drugs Type, 2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
5.1. Tocolytic Drugs
5.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Beta Mimetic
5.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Calcium Channel Blockers
5.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. NSAIDS
5.4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Corticosteroids
5.5.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Magnesium Sulphate
5.6.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Antibiotics
5.7.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Others
5.8.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
6. Asia Pacific Preterm Labor Treatment Market By Dosage form, 2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
6.1. Tablets
6.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Capsules
6.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Injection
6.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Asia Pacific Preterm Labor Treatment Market By End User, 2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Pediatric and Neonatal Clinics
7.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Nursing Homes
7.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Pharmacy
7.4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8. Asia Pacific Preterm Labor Treatment Market By Country, 2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
8.1. China
8.1.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. India
8.2.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Australia and New Zealand (ANZ)
8.3.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Japan
8.4.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Rest of APAC
8.5.1. Market Analysis, 2020-2024 and Forecast 2025-2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.China Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
9.1. Drugs Type Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Tocolytic Drugs
9.1.2.Beta Mimetic
9.1.3.Calcium Channel Blockers
9.1.4.NSAIDS
9.1.5.Corticosteroids
9.1.6.Magnesium Sulphate
9.1.7.Antibiotics
9.1.8.Others
9.2.  Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Tablets
9.2.2.Capsules
9.2.3.Injection
9.3.  End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Pediatric and Neonatal Clinics
9.3.3.Nursing Homes
9.3.4.Pharmacy
10.India Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
10.1. Drugs Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Tocolytic Drugs
10.1.2.Beta Mimetic
10.1.3.Calcium Channel Blockers
10.1.4.NSAIDS
10.1.5.Corticosteroids
10.1.6.Magnesium Sulphate
10.1.7.Antibiotics
10.1.8.Others
10.2.  Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Tablets
10.2.2.Capsules
10.2.3.Injection
10.3.  End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Pediatric and Neonatal Clinics
10.3.3.Nursing Homes
10.3.4.Pharmacy
11.Australia and New Zealand (ANZ) Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
11.1. Drugs Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Tocolytic Drugs
11.1.2.Beta Mimetic
11.1.3.Calcium Channel Blockers
11.1.4.NSAIDS
11.1.5.Corticosteroids
11.1.6.Magnesium Sulphate
11.1.7.Antibiotics
11.1.8.Others
11.2.  Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Tablets
11.2.2.Capsules
11.2.3.Injection
11.3.  End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Pediatric and Neonatal Clinics
11.3.3.Nursing Homes
11.3.4.Pharmacy
12.Japan Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
12.1. Drugs Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Tocolytic Drugs
12.1.2.Beta Mimetic
12.1.3.Calcium Channel Blockers
12.1.4.NSAIDS
12.1.5.Corticosteroids
12.1.6.Magnesium Sulphate
12.1.7.Antibiotics
12.1.8.Others
12.2.  Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Tablets
12.2.2.Capsules
12.2.3.Injection
12.3.  End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Pediatric and Neonatal Clinics
12.3.3.Nursing Homes
12.3.4.Pharmacy
13.Rest of APAC Preterm Labor Treatment Market ,2020-2024 and Forecast 2024-2031 (Sales Value USD Million)
13.1. Drugs Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Tocolytic Drugs
13.1.2.Beta Mimetic
13.1.3.Calcium Channel Blockers
13.1.4.NSAIDS
13.1.5.Corticosteroids
13.1.6.Magnesium Sulphate
13.1.7.Antibiotics
13.1.8.Others
13.2.  Dosage form Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Tablets
13.2.2.Capsules
13.2.3.Injection
13.3.  End User Analysis 2020-2024 and Forecast 2024-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Pediatric and Neonatal Clinics
13.3.3.Nursing Homes
13.3.4.Pharmacy
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Pfizer
14.2.2.Novartis
14.2.3.Merck & Co
14.2.4.Sanofi
14.2.5.Johnson and Johnson
14.2.6.GlaxoSmithKline
14.2.7.AstraZeneca
14.2.8.Cipla
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Pfizer
  • Novartis
  • Merck & Co
  • Sanofi
  • Johnson and Johnson
  • GlaxoSmithKline
  • AstraZeneca
  • Cipla

Related Industry Reports